About Urologicum Duisburg
Clinical Trials at Urologicum Duisburg
During the past decade, Urologicum Duisburg conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Urologicum Duisburg" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Pfizer" with 2 trials
sponsored, "RhoVac APS" with 1 trials sponsored, "Universität des Saarlandes" with 1 trials sponsored and "Westfälische Wilhelms-Universität Münster"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Urologicum Duisburg"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Janssen Pharmaceutica N.V., Belgium" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Urologicum Duisburg
According to Clinical.Site data, the most researched conditions in "Urologicum Duisburg" are
"Urinary Bladder Neoplasms" (3 trials), "Prostate Cancer" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Non-muscle Invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Urologicum Duisburg" in a lesser frequency.
Clinical Trials Intervention Types at Urologicum Duisburg
Most popular intervention types in "Urologicum Duisburg" are "Drug" (10 trials), "Biological" (3 trials), "Other" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetrelimab" (2 trials), "Erdafitinib" (2 trials), "Niraparib" (2 trials), "Placebo" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Urologicum Duisburg
The vast majority of trials in "Urologicum Duisburg" are
6 trials for "Male" genders and 5 trials for "All" genders.
Clinical Trials Status at Urologicum Duisburg
Currently, there are NaN active trials in "Urologicum Duisburg".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Urologicum Duisburg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Urologicum Duisburg, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".